HPV Vaccination and the Risk of Invasive Cervical Cancer.
New England Journal of Medicine, 2020 BACKGROUND The efficacy and effectiveness of the quadrivalent human papillomavirus (HPV) vaccine in preventing high-grade cervical lesions have been shown.
J. Lei +8 more
semanticscholar +1 more source
Vaccine Hesitancy, Acceptance, and Anti-Vaccination: Trends and Future Prospects for Public Health.
Annual Review of Public Health, 2021 An often-stated public health comment is that "vaccination is a victim of its own success." While the scientific and medical consensus on the benefits of vaccination is clear and unambiguous, an increasing number of people are perceiving vaccines as ...
È. Dubé +3 more
semanticscholar +1 more source
MMWR. Morbidity and mortality weekly report, 2021 The Advisory Committee on Immunization Practices (ACIP) recommends that adolescents aged 11-12 years routinely receive tetanus, diphtheria, and acellular pertussis (Tdap); meningococcal conjugate (MenACWY); and human papillomavirus (HPV) vaccines.
C. Pingali +8 more
semanticscholar +1 more source
Impact of a mass vaccination campaign against a meningitis epidemic in a refugee camp. [PDF]
, 1996 Serogroup A meningococcus epidemics occurred in refugee populations in Zaire in August 1994. The paper analyses the public health impact of a mass vaccination campaign implemented in a large refugee camp.
Blok, L +5 more
core +2 more sources
Virus-Like Particle-Mediated Vaccination against Interleukin-13 May Harbour General Anti-Allergic Potential beyond Atopic Dermatitis [PDF]
, 2020 Virus-like particle (VLP)-based anti-infective prophylactic vaccination has been established in clinical use. Although validated in proof-of-concept clinical trials in humans, no VLP-based therapeutic vaccination against self-proteins to modulate chronic
Foerster, John, Molęda, Aleksandra
core +2 more sources
Effect of Vaccination on Household Transmission of SARS-CoV-2 in England
New England Journal of Medicine, 2021 Vaccination against SARS-CoV-2 with either ChAdOx1 nCoV-19, produced by AstraZeneca, or BNT162b2, produced by Pfizer, has been shown to produce a robust antibody response (1,2), and is effective in both preventing cases and reducing the severity of COVID-
Ross J. Harris +5 more
semanticscholar +1 more source
Heterogeneity in the spread and control of infectious disease: consequences for the elimination of canine rabies [PDF]
, 2015 Understanding the factors influencing vaccination campaign effectiveness is vital in designing efficient disease elimination programmes. We investigated the importance of spatial heterogeneity in vaccination coverage and human-mediated dog movements for ...
Cleaveland, Sarah +9 more
core +2 more sources
Covid-19 vaccination hesitancy
British medical journal, 2021 • Lack of confidence in vaccines for covid-19 poses direct and indirect threats to health, and could derail efforts to end the current pandemic • Concerns about unknown future effects, side effects, and a lack of trust are common reasons given by people ...
M. Razai +4 more
semanticscholar +1 more source
Impact of communicative and informative strategies on influenza vaccination adherence and absenteeism from work of health care professionals working at the university hospital of palermo, Italy: A quasi-experimental field trial on twelve influenza seasons [PDF]
, 2019 Every year, about 20% of health care workers (HCWs) acquire influenza, continuing to work and encouraging virus spreading. Influenza vaccination coverage rates and absenteeism from work among HCWs of the University Hospital (UH) of Palermo were analyzed ...
Bono S. +8 more
core +1 more source
Italian Journal of Pediatrics, 2019 Background Invasive meningococcal disease is a serious global health threat in the world; in 2016, the European Centre for Disease Control and Prevention reported 3280 confirmed cases (including 304 deaths) of Invasive Meningococcal Diseases in Europe ...
L. Nicolosi +7 more
doaj +1 more source